Catalyst Event

Alnylam Pharmaceuticals Inc (ALNY) · Other

From KEDI U.S. Tech100 90% Participation + Daily Options Premium Index (KUSTC100P)

5/27/2026, 12:00:00 AM

OtherSentiment: Neutral

Announced the results of its 2026 Annual Meeting held on May 20, where shareholders re-elected three directors and approved executive compensation. The company also announced the expansion of its Board of Directors from ten to eleven members, effective June 1, 2026. Low importance is estimated as routine governance matters typically result in minimal price impact scheduled.

Korean Translation

2026년 5월 20일에 개최된 연례 주주총회 결과를 발표했으며, 이사 3명을 재선임하고 임원 보상안을 승인함. 또한 2026년 6월 1일부로 이사회를 10명에서 11명으로 확대한다고 발표함. 통상적인 지배구조 관련 사항으로 주가 영향이 미미할 것으로 예상되어 '낮음'으로 평가하며 발표가 예정됨.

Related Recent Events

View Full Timeline